Determination of nicotine and nicotine metabolites in urine by hydrophilic interaction chromatography-tandem mass spectrometry: Potential use of smokeless tobacco products by ice hockey players

Journal of Chromatography A

Volumn 1217, Issue 48, 2010, Pages 7528-7538

  Marclay, François ^a   Saugy, Martial ^a  

^a UNIVERSITY CENTER OF LEGAL MEDICINE   (Switzerland)

Author keywords

HILIC MS MS; Ice hockey players; Nicotine exposure; Smokeless tobacco products; Urine

Indexed keywords

HILIC-MS/MS; ICE HOCKEY PLAYERS; NICOTINE EXPOSURE; SMOKELESS TOBACCO PRODUCTS; URINE;

BIOMOLECULES; BODY FLUIDS; CONCENTRATION (PROCESS); ELECTROSPRAY IONIZATION; HYDROPHILICITY; ICE; LIQUID CHROMATOGRAPHY; LIQUIDS; MASS SPECTROMETRY; METABOLISM; METABOLITES; SOLVENT EXTRACTION; TOBACCO;

PYRIDINE;

3' HYDROXYCOTININE; COTININE; COTININE N' OXIDE; NICOTINE; NICOTINE GUM; NICOTINE N' OXIDE; UNCLASSIFIED DRUG;

ARTICLE; CALIBRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; ENANTIOSELECTIVITY; HUMAN; HYDROPHILIC INTERACTION CHROMATOGRAPHY; ICE HOCKEY; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; PRIORITY JOURNAL; SMOKELESS TOBACCO; TANDEM MASS SPECTROMETRY; URINALYSIS;

CHROMATOGRAPHY, LIQUID; HOCKEY; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; NICOTINE; TANDEM MASS SPECTROMETRY; TOBACCO, SMOKELESS;

NICOTIANA TABACUM;

EID: 78149361342     PISSN: 00219673     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chroma.2010.10.005     Document Type: Article

References (45)

1. Hukkanen J., Jacob P., Benowitz N. Pharmacol. Rev. 2005, 57:79.
2. Yildiz D. Toxicon 2004, 43:619.
3. Metz C., Gregersen P., Malhotra A. Med. Clin. North Am. 2004, 88:1399.
4. Benowitz N., Jacob P., Fong I., Gupta S. J. Pharmacol. Exp. Ther. 1994, 268:296.
5. Tricker A. Toxicology 2003, 151.
6. Meger M., Meger-Kossien I., Schuler-Metz A., Janket D., Scherer G. J. Chromatogr. A 2002, 778:251.
7. Miller E., Norris H-R.K., Rollins D.E., Tiffany S.T., Wilkins D.G. J. Chromatogr. B 2009, 878:725.
8. Heavner D., Richardson J., Morgan W.T., Ogden M.W. Biomed. Chromatogr. 2005, 19:312.
9. Pellegrini M., Marchei E., Rossi S., Vagnarelli F., Durgbanshi A., Garcia-Algar O., Vall O., Pichini S. Rapid Commun. Mass Spectrom. 2007, 21:2693.
10. Xu X., Iba M., Weisel C. Clin. Chem. 2004, 50:2323.
11. Gray T., Shakleya D., Huestis M. J. Chromatogr. B 2008, 863:107.
12. Kataoka H., Inoue R., Yagi K., Saito K. J. Pharm. Biomed. Anal. 2009, 49:108.
13. Shakleya D.M., Huestis M.A. Anal. Bioanal. Chem. 2009, 395:2349.
14. Shakleya D.M., Huestis M.A. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2009, 877:3537.
15. Benowitz N. Annu. Rev. Pharmacol. Toxicol. 1996, 36:597.
16. Herman A.I., Sofuoglu M. Addict. Biol. 2010, 15:250.
17. Heishman S.J., Kleykamp B.A., Singleton E.G. Psychopharmacology (Berl) 2010, 210:453.
18. Schweizer C., Cardis C., Saugy M., Rivier L. Recent Advances in Doping Analyses 1997, 269. Cologne. W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke (Eds.).
19. Connolly G.N., Orleans C.T., Blum A. Am. J. Public Health 1992, 82:351.
20. Severson H.H., Klein K., Lichtensein E., Kaufman N., Orleans C.T. Tob. Control 2005, 14:31.
21. World Anti-Doping Agency (WADA), The World Anti-Doping Code, The 2009 Prohibited List, Montreal, 2009, (accessed September 2010). http://www.wada-ama.org/.
22. World Anti-Doping Agency (WADA), The World Anti-Doping Code, The 2010 Prohibited List, Montreal, 2010, (accessed September 2010). http://www.wada-ama.org/.
23. B. Yue, M.M. Kushnir, F.M. Urry, A.L. Rockwood, in: Clinical Applications of Mass Spectrometry, 2010, p. 389.
24. Nguyen H.P., Schug K.A. J. Sep. Sci. 2008, 31:1465.
25. McCalley D.V. J. Chromatogr. A 2010, 1217:858.
26. World Anti-Doping Agency (WADA), Identification Criteria for Qualitative Assays, Technical Document TD2003IDCR, Montreal, 2003, (accessed September 2010). http://www.wada-ama.org/.
27. Food and Drug Administration, Guidance for Industry: Bioanalytical Method Validation, US Department of Health and Human Services, FDA, Centre for Drug Evaluation and Research, Rockville, MD, 2001.
28. Viswanathan C.T., Bansal S., Booth B., DeStefano A.J., Rose M.J., Sailstad J., Shah V.P., Skelly J.P., Swann P.G., Weiner R. Pharm. Res. 2007, 24:1962.
29. Rozet E., Ceccato A., Hubert C., Ziemons E., Oprean R., Rudaz S., Boulanger B., Hubert P. J. Chromatogr. A 2007, 1158:111.
30. Boulanger B., Chapuzet E., Chiap P., Cohen N., Compagnon P.A., Dewe W., Feinberg M., Lallier M., Laurentie M., Mercier N., Muzard G., Nivet C., Valat L. STP Pharma Pratiques 2003, 13:101.
31. Rudaz S., Souverain S., Schelling C., Deleers M., Klomp A., Norris A., Vu T.L., Ariano B., Veuthey J.L. Anal. Chim. Acta 2003, 492:271.
32. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Anal. Chem. 2003, 75:3019.
33. Tuomi T., Johnsson T., Reijula K. Clin. Chem. 1999, 45:2164.
34. Boswell C., Curvall M., Elswick R., Leyden D. Biomarkers 2000, 5:341.
35. World Anti-Doping Agency (WADA), The World Anti-Doping Code, The 2009 International Standards for Laboratories, Montreal, 2009, (accessed September 2010). http://www.wada-ama.org/.
36. World Anti-Doping Agency (WADA), The World Anti-Doping Code, The Code, Montreal, 2009, (accessed September 2010). http://www.wada-ama.org/.
37. Organisation des Nations Unies pour l'éducation, la science et la culture (UNESCO), International Convention Against Doping In Sport 2005, The 2009 International Standards for Laboratories, Paris, 2005, (accessed September 2010). http://www.unesco.org/.
38. World Health Organization (WHO), WHO Report on the Global Tobacco Epidemic, 2009: Implementing Smoke-Free Environments, Geneva, 2009, (accessed September 2010). http://www.who.int/.
39. Office Fédérale de la Santé Publique (OFSP), Résumé du rapport sur le tabagisme passif 2009, Le tabagisme passif dans la population suisse 2008, Zürich, 2009, (accessed September 2010). http://www.bag.admin.ch/.
40. Benowitz N. Epidemiol. Rev. 1996, 18:188.
41. Benowitz N., Pomerleau O., Pomerleau C., Jacob P. Nicotine Tob. Res. 2003, 5:621.
42. Hamari A., Toljamo T., Nieminen P., Kinnula V.L. Ann. Med. 2010, 42:512.
43. Goic-Barisic I., Bradaric A., Erceg M., Barisic I., Foretic N., Pavlov N., Tocilj J. Coll. Antropol. 2006, 30:615.
44. Tchissambou B.P., Massamba A., Babela J.R., Mouanou J.K., Mboussa J., Senga P. Rev. Mal. Respir. 2004, 21:59.
45. Louie D. Can. Respir. J. 2001, 8:289.